These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 28542921)
1. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes. Vaitaitis GM; Waid DM; Yussman MG; Wagner DH Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921 [TBL] [Abstract][Full Text] [Related]
2. CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells. Amrani A; Serra P; Yamanouchi J; Han B; Thiessen S; Verdaguer J; Santamaria P Immunity; 2002 May; 16(5):719-32. PubMed ID: 12049723 [TBL] [Abstract][Full Text] [Related]
3. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107 [TBL] [Abstract][Full Text] [Related]
4. CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. Baker RL; Wagner DH; Haskins K J Autoimmun; 2008 Dec; 31(4):385-92. PubMed ID: 18951762 [TBL] [Abstract][Full Text] [Related]
5. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40. Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180 [TBL] [Abstract][Full Text] [Related]
6. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Van Belle TL; Nierkens S; Arens R; von Herrath MG Immunity; 2012 Jun; 36(6):1060-72. PubMed ID: 22579473 [TBL] [Abstract][Full Text] [Related]
8. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685 [TBL] [Abstract][Full Text] [Related]
9. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution. Vong AM; Daneshjou N; Norori PY; Sheng H; Braciak TA; Sercarz EE; Gabaglia CR J Transl Med; 2011 Jul; 9():101. PubMed ID: 21722394 [TBL] [Abstract][Full Text] [Related]
10. CD154 Costimulation Shifts the Local T-Cell Receptor Repertoire Not Only During Thymic Selection but Also During Peripheral T-Dependent Humoral Immune Responses. Fähnrich A; Klein S; Sergé A; Nyhoegen C; Kombrink S; Möller S; Keller K; Westermann J; Kalies K Front Immunol; 2018; 9():1019. PubMed ID: 29867987 [TBL] [Abstract][Full Text] [Related]
11. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells. Pane JA; Webster NL; Zufferey C; Coulson BS Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305 [TBL] [Abstract][Full Text] [Related]
12. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L. Nakayama Y; Brinkman CC; Bromberg JS Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408 [TBL] [Abstract][Full Text] [Related]
13. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. Bour-Jordan H; Salomon BL; Thompson HL; Szot GL; Bernhard MR; Bluestone JA J Clin Invest; 2004 Oct; 114(7):979-87. PubMed ID: 15467837 [TBL] [Abstract][Full Text] [Related]
14. L-selectin is not required for T cell-mediated autoimmune diabetes. Friedline RH; Wong CP; Steeber DA; Tedder TF; Tisch R J Immunol; 2002 Mar; 168(6):2659-66. PubMed ID: 11884430 [TBL] [Abstract][Full Text] [Related]
15. CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. McGregor CM; Schoenberger SP; Green EA Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9345-50. PubMed ID: 15192149 [TBL] [Abstract][Full Text] [Related]
16. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094 [TBL] [Abstract][Full Text] [Related]
17. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136 [TBL] [Abstract][Full Text] [Related]
18. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. Vaitaitis GM; Wagner DH PLoS One; 2008 Apr; 3(4):e2076. PubMed ID: 18446238 [TBL] [Abstract][Full Text] [Related]
19. CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity. Vaitaitis GM; Wagner DH Mol Immunol; 2010 Aug; 47(14):2303-13. PubMed ID: 20646763 [TBL] [Abstract][Full Text] [Related]
20. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells. Lee MH; Lee WH; Todorov I; Liu CP J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]